Latest
New Vaccine Could Protect Against Many Coronaviruses
The vaccine would be easy to store and transport, even in remote corners of the globe, and could be manufactured in bulk using existing vaccine factories. Plus it could cost only about $1 a dose.
Good News in the Battle Against the Most Common Childhood Cancer
Stem cell transplants can slash the relapse rate in children who receive CAR T-cell therapy for acute lymphoblastic leukemia, a new study finds.
Questions About the Johnson & Johnson COVID-19 Vaccine?
Our Bill Petri Jr., MD, PhD, has answers.
STAT Madness: The Outcome
We didn't win, but it was a darn good showing.
Rescuing Billion-Dollar Treatments for Solid Tumors
Our Jogender Tushir-Singh, PhD, has discovered why promising treatments for solid tumors failed in clinical trials, and that has the potential to revive these billion-dollar disappointments.
We Made It to the Final Four, But We Need Your Vote!
The good news: We made it into the Final Four of STAT Madness. The bad news: Our new opponent has an alarming lead.